The global ultrasound AI market was valued at USD 1.82 billion in 2025 and is projected to reach USD 13.56 billion by 2033, expanding at a CAGR of 28.55% from 2026 to 2033. This strong growth trajectory is primarily driven by the rising demand for accurate and early disease detection, a significant increase in imaging volumes across healthcare systems, and supportive government initiatives and regulatory frameworks that encourage the adoption of artificial intelligence in medical imaging. As healthcare providers aim to improve diagnostic precision while managing operational efficiency, ultrasound AI solutions are becoming an integral component of modern clinical workflows.

Market Size & Forecast

• 2025 Market Size: USD 1.82 Billion
• 2033 Projected Market Size: USD 13.56 Billion
• CAGR (2026-2033): 28.55%
• North America: Largest market in 2025
• Asia Pacific: Fastest growing market

Key Market Trends & Insights

• North America ultrasound AI market held the largest share of over 52% of the global market in 2025. This dominance can be attributed to the presence of advanced healthcare infrastructure, high adoption of digital health technologies, and strong regulatory support. The region also benefits from significant investments in AI research and development, enabling rapid commercialization of innovative solutions.
• The ultrasound AI industry in the U.S. is expected to grow significantly over the forecast period. This growth is driven by increasing healthcare spending, widespread adoption of AI-enabled diagnostic tools, and a strong focus on improving patient outcomes through early detection and precision medicine approaches.
• Based on component, hardware/AI-enabled devices held the largest market share of over 48% in 2025. The integration of AI directly into ultrasound machines enhances real-time analysis capabilities and reduces reliance on external software platforms, making these devices highly attractive to healthcare providers.
• Based on application, the cardiology/echocardiography segment held the highest market share of over 38% in 2025. The high prevalence of cardiovascular diseases and the need for accurate cardiac imaging are driving the adoption of AI-powered echocardiography solutions.
• Based on end use, the hospitals segment held the largest market share of over 48% in 2025. Hospitals are the primary users of advanced imaging technologies due to their high patient volumes and need for comprehensive diagnostic capabilities.

Download a free sample copy of the Ultrasound AI market report to understand detailed coverage and inclusions in the final report

In parallel, the increasing focus on cost-efficiency in healthcare delivery continues to accelerate the adoption of AI-powered ultrasound systems. Healthcare institutions are under pressure to reduce diagnostic errors, minimize repeat imaging, and optimize resource utilization. Technological advancements in machine learning, natural language processing, and computer vision are enabling ultrasound AI tools to deliver faster, more reliable interpretations. These advancements are particularly valuable in high-volume clinical settings, where speed and accuracy are critical for patient outcomes.

The growing need for precise early disease detection is another major factor contributing to market expansion. The rising prevalence of chronic conditions such as cancer, cardiovascular diseases, and neurological disorders has heightened the demand for advanced imaging technologies capable of supporting early diagnosis and intervention. AI-enhanced ultrasound systems can identify subtle abnormalities that may be missed during manual interpretation. For example, a meta-analysis of 18 studies published in December 2025 demonstrated that ultrasound-based AI models achieved significantly higher diagnostic accuracy for ovarian cancer compared to traditional sonography, with internal validation sensitivity and specificity reaching 0.95 and an AUC of 0.98, while external validation showed an AUC of 0.91. In contrast, sonographers exhibited lower sensitivity and specificity levels, highlighting the clinical value of AI integration.

Looking for more specific insights? Customize this report to suite your business needs

Moreover, automated measurements and AI-driven risk assessment tools are improving diagnostic consistency by reducing variability among radiologists and clinicians. These capabilities also support the development of personalized treatment strategies, aligning with the broader shift toward precision medicine. Technological innovations such as FDA-cleared AI tools for heart failure and lung evaluation on portable ultrasound devices demonstrate how AI is enhancing point-of-care diagnostics. The increasing emphasis on value-based care models further reinforces the need for efficient, accurate, and scalable diagnostic solutions, thereby boosting the adoption of ultrasound AI technologies.

Advancements in deep learning architectures are also playing a crucial role in transforming the ultrasound AI landscape. Modern algorithms are capable of analyzing complex imaging data with high accuracy, enabling improved detection of conditions such as gallstones, cholecystitis, and other abnormalities. A study published in January 2026 highlighted the use of advanced neural network models, including squeeze-and-excitation capsule networks combined with convolutional bidirectional LSTM, to analyze ultrasound image sequences. This approach demonstrated superior performance compared to traditional diagnostic methods, emphasizing the growing reliability of AI-based systems in clinical applications.

Workforce shortages and skill gaps in sonography and radiology are additional factors driving market growth. Many healthcare systems face a lack of experienced professionals, which can lead to delays in diagnosis and increased workload for existing staff. AI-assisted ultrasound solutions help address this challenge by providing real-time guidance, automated image acquisition, and standardized measurements. These tools enable less experienced operators to perform high-quality scans with reduced training requirements. In pediatric imaging, for instance, AI is being used to enhance structural recognition, improve image consistency, and support non-expert clinicians in diagnosing a wide range of conditions. This capability is particularly valuable in underserved or resource-limited settings, where access to specialized expertise may be limited.

Explore Grand View Horizon to see global and regional level statistics related to the Ultrasound AI Market

Key Ultrasound AI Company Insights

The competitive landscape of the ultrasound AI market is characterized by the presence of several established players and emerging innovators. Companies are actively focusing on strategies such as new product development, strategic collaborations, and partnerships to strengthen their market position and expand their global footprint. Continuous innovation in AI algorithms and integration capabilities is a key differentiator among market participants.

Leading companies in the ultrasound AI market include GE Healthcare, Koninklijke Philips N.V., Siemens Healthineers, EchoNous Inc., UltraSight, iCardio.ai, Sonio SAS (a SAMSUNG Company), Koios Medical, SamsungHealthcare.com, FUJIFILM Corporation, Clarius, Caption Care, and Us2.ai. These organizations collectively contribute to technological advancements and set industry benchmarks through their extensive product portfolios and research initiatives.

Conclusion

The ultrasound AI market is undergoing rapid transformation, driven by technological innovation, increasing clinical demand for early and accurate diagnosis, and systemic healthcare challenges such as workforce shortages and rising costs. The integration of artificial intelligence into ultrasound imaging is not only enhancing diagnostic accuracy but also improving workflow efficiency and accessibility of care. As advancements in machine learning and imaging analytics continue to evolve, the market is expected to witness sustained growth across both developed and emerging regions. The combination of strong market fundamentals, expanding applications, and continuous innovation positions ultrasound AI as a critical component of the future healthcare ecosystem.

Looking for a report customized to your requirements? Explore our Custom Research Offering

Grand View Research offers

• Focused market intelligence reports on specific geographies or high-growth segments.
• Extended forecast timelines for long-term planning.
• Competitor Benchmarking and Supply Chain Analysis
• Inclusion of regulatory and policy assessments.
• Inclusion of custom data models, KPIs, or applications unique to your business
• Specific high-impact Data Decks and Tables to support effective decision making

And much more…

Browse our new services – Grand View Brainshare